✦ LIBER ✦

28 Results of a phase III trial comparing taxol-cisplatin (TC) regimens to etoposide-cisplatin (EC) in non-small cell lung cancer (NSCLC)

✍ Scribed by Bonomi, P.; Kim, C.; Kugler, K.; Johnson, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic evaluation in a randomized phas

✍ Sacristán, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Randomized phase III trial of Taxol®/Car

✍ Rosell, R.; Gatzemeier, U.; Betticher, D.; Keppler, U.; Macha, H.N.; Pirker, R.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Comparison of Tirazone (Tirapazamine) an

✍ Shepherd, F; Koschel, G; von Pawel, J; Gatzmeier, U; Van Zandwiyk, N; Woll, P; V 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Cisplatin/ifosfamide/vinblastine (VIP) v

✍ Kosmidis, P.; Mylonakis, N.; Fountzilas, G.; Pavlidis, N.; Samantas, E.; Karabel 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Preliminary results of a randomised phas

✍ Costa, A; Barradas, P; Cristóvão, M; Alves, P; Melo, M.J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A phase II trial with oral etoposide (VP

✍ Gracia, J.M.; Fernández, R.; Cueva, J.; Virizuela, J.A.; García, E.; Sanz, A.; L 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 142 KB